DR. ISKRA PUSIC MD NPI 1164699161

NPI Details

DR. Iskra Pusic, MD is a medical oncology internal medicine in Saint Louis, MO with 29 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Iskra Pusic, MD NPI is 1164699161. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

4500 FOREST PARK AVE
DIV IM BONE MARROW TRANSPLANT, 5TH, 6TH, 8TH FL
SAINT LOUIS, MO
ZIP 63108-114
Phone: (314) 454-8304
Fax: (314) 454-5902

The NPI 1164699161 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Unclassified drugs (HCPCS:J3490)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Transfusion of blood or blood products (HCPCS:36430)

The enumeration date for this NPI number is 5/9/2008 and was last updated on 4/17/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.